Help

Our vision: At OWP, we envision a world where all people get the best level of medical care regardless of who they are or where they live. Our mission: OWP neuiMed delivers quality branded generic epilepsy medications that are replicable and fairly priced. Our strategic focus is to support neurologists and patients in the U.S. with beneficial products and to use the majority of profits to provide resources for those living with epilepsy in under-resourced areas of the world. We do this by partnering with the ROW Foundation to improve the diagnosis and treatment available to these under-resourced patients and their families. This symbiotic relationship enables us to better serve the entire epilepsy community. Thus our motto: One World. One Standard.

OWP neuiMed was started in 2016 to help alleviate some of the medical and pharmaceutical injustices that exist between people in low- and middle-income countries and wealthier, more economically-developed countries. A small group of individuals with significant pharmaceutical and financial experience came together to discuss creative ways to address this issue. From those discussions was conceived a hybrid partnership between a for-profit pharmaceutical company and a nonprofit charitable foundation. This unique, cooperative model became the basis for our social enterprise―OWP neuiMed and the ROW Foundation.

By working together and focusing our efforts on people living in under-resourced areas, OWP neuiMed and the ROW Foundation can help bring hope, justice and relief from suffering to millions of epilepsy patients and their families around the world.

The business model for OWP Pharmaceuticals is very different from Big Pharma models, especially a traditional startup Pharma company. The unique combination of a “for profit” and “not for profit” company working together is not designed to maximize profits or to be sold to a larger pharmaceutical company. It is built to maximize the treatment of epilepsy globally through profits generated by OWP, which are used by the ROW Foundation for humanitarian purposes.

Nearly 80% of people with epilepsy live in under-developed regions, with about 75% of them not having access to epilepsy diagnosis and treatment. The knowledge and medicines already exist to bring hope and a brighter future to millions. Addressing this disparity and injustice through our strategic partnership and intentional action is why we exist.